← Back to news

Markets

Here’s What Analysts Think About Banco Bilbao Vizcaya Argentaria (BBVA)

Y

What Does Wall Street Think About Banco Santander (SAN)?

Y

Why is Equinor ASA (EQNR) One of the Best Affordable Stocks Under $30?

Y

Piper Believes Stellantis N.V. (STLA) Has the Potential for “Rapid Upside” – Here’s Why

Y

Barclays Maintains Overweight Rating on Energy Transfer LP (ET)

Y

Where is Vale S.A. (VALE) Headed According to Analysts?

Y

This is What Analysts Are Saying About Cenovus Energy Inc. (CVE)

Y

Where is JD.com (JD) Headed According to the Street?

Y

Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30

Y

2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run

Y

Here is What Analysts Think About AT&T Inc. (T)

Y

Here’s What Analysts Think About Fortinet (FTNT)

Y

What Do Analysts Think About KLA Corporation (KLAC)?

Y

Where is Palantir Technologies Inc. (PLTR) Headed According to Analysts?

Y

This is What Analysts Think About Arista Networks (ANET)

Y

What Does Wall Street Think About ServiceNow (NOW)?

Y

Where is Eli Lilly and Company (LLY) Headed According to Analysts?

Y

Is Advanced Micro Devices (AMD) One of the Best Long Term Growth Stocks to Buy According to Hedge Funds?

Y

This is What The Street Thinks About Uber Technologies (UBER)

Y

Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook

Y

Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)

Y

Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why

Y

Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026

Y

Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

Y

Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept

Y

Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Y

Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now?

Y

Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus

Y

Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating

Y

Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib

Y

HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating

Y

Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN)

Y

Senate Delays Clarity Act Meeting After Coinbase Opposition

Y

Silver surge masks quiet risk

Y

CME Group to Launch Cardano, Chainlink, Stellar Futures on Feb 9

Y

European corporates expected to deliver worst earnings growth in past seven quarters

Y

AI Is Rewriting Global Power Needs, Creating a Massive Opportunity for This Engineering and Construction Company

Y

Bank of America resets IBM price target before earnings

Y

Why Taiwan Semiconductor Stock Surged Today

Y

Insteel (IIIN) Q1 2026 Earnings Call Transcript

Y

First Horizon (FHN) Q4 2025 Earnings Transcript

Y

ADTRAN Eyes 2026 Momentum at Needham Conference as Optical Demand, Europe Huawei Swap Accelerate

Y

Trump Tariffs Will Clear The Supreme Court Hurdle? Crypto Bettors Say: No

Y

Steven Cress' Top 10 Stocks For 2026

S

Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase

Y

Worried About a Stock Market Crash in 2026? Avoid This 1 Common Investing Mistake.

Y

If I Could Own Only 1 Quantum Computing Stock in 2026, This Would Be It

Y

A Wealthy Connecticut Homeowner Asks If Anyone Regrets Moving To A Cheaper State? 'Absolutely. From SoCal To TX. Don't Recommend It'

Y

Morgan Stanley beats consensus, defends keeping older goals

Y

Rosenblatt reiterates buy on Bullish even as IPO unlock looms

Y